YES-3Homo sapiens (Human)Cancer cell line
AI Summary
No AI-generated summary available for this cell line.
Basic Information
| Database ID | CVCL_E323 |
|---|---|
| Species | Homo sapiens (Human) |
| Tissue Source | Pleural effusion[UBERON:UBERON_0000175] |
Disease Information
| Disease | Squamous cell carcinoma of the esophagus |
|---|
DepMap Information
Publications
Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways.
Kusukawa J., Kage M., Shirouzu K., Yamana H.
Mol. Cancer Ther. 9:1842-1851(2010).
Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
Yoshino S., Hazama S.
Oncol. Rep. 20:155-163(2008).
The influence of interleukin-6 on the growth of human esophageal cancer cell lines.
Suzuki T.
J. Interferon Cytokine Res. 16:1001-1006(1996).
Cytokine mRNA expression patterns in human esophageal cancer cell lines.
Hazama S., Suzuki T.
J. Interferon Cytokine Res. 15:1005-1009(1995).
Establishment and characterization of human esophageal carcinoma cell lines -- especially the role of the serum-free culture.
Murakami T., Nakamura M., Kusanagi H., Suzuki T.
Nihon Geka Gakkai Zasshi 92:1563-1570(1991).
Effect of epidermal growth factor (EGF) on human esophageal cancer cell lines in a protein-free medium and the expression of EGF receptors on the cells.
Kusanagi H.
Nihon Shokaki Geka Gakkai Zasshi 27:1885-1891(1994).